DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

28.45B

Market cap28.45B

Price-Earnings ratio

31.54

Price-Earnings ratio31.54

Dividend yield

—

Dividend yield—

Average volume

8.91M

Average volume8.91M

High today

$73.82

High today$73.82

Low today

$72.40

Low today$72.40

Open price

$72.89

Open price$72.89

Volume

9.26M

Volume9.26M

52 Week high

$89.98

52 Week high$89.98

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $73.61, giving the company a market capitalization of 28.45B. It carries a P/E multiple of 31.54.

On 2026-05-30, DexCom(DXCM) stock moved within a range of $72.40 to $73.82. With shares now at $73.61, the stock is trading +1.7% above its intraday low and -0.3% below the session's peak.

Trading volume for DexCom(DXCM) stock has reached 9.26M, versus its average volume of 8.91M.

The stock's 52-week range extends from a low of $54.11 to a high of $89.98.

DXCM News

Simply Wall St 40m

How Investors May Respond To DexCom Global App Recalls Over Delayed Glucose Alerts

In April 2026, Dexcom voluntarily initiated Class II global recalls of its G7, ONE and ONE+ iOS and watchOS CGM apps after an FDA enforcement report highlighted...

MarketWatch 1d

DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch

...

TipRanks 2d

Dexcom Shareholders Approve Board, Auditor and Compensation

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

84%

of 31 ratings

Buy

83.9%

Hold

16.1%

Sell

More DXCM News

TipRanks 3d

DexCom price target raised to $84 from $79 at Citi

Citi raised the firm’s price target on DexCom (DXCM) to $84 from $79 and keeps a Buy rating on the shares. The firm updated models in the medical technology spa...

Simply Wall St 6d

Assessing DexCom Valuation After Q1 2026 Beat Analyst Upgrades And Dexcom Flex Launch

DexCom (DXCM) has drawn fresh attention after multiple analysts shifted to “Outperform.” This coincides with robust Q1 2026 revenue of US$1.19b and the launch o...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.